US2016083699A1PendingUtilityA1

High efficiency flp site-specific recombination in mammalian cells using an optimized flp gene

Assignee: HUTCHINSON FRED CANCER RESPriority: Jul 7, 2006Filed: Dec 4, 2015Published: Mar 24, 2016
Est. expiryJul 7, 2026(expired)· nominal 20-yr term from priority
C12N 2510/00C12N 15/79C07H 21/04C12N 9/00C12N 2800/30C12N 15/63C12N 9/14C12Y 306/00
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides an optimized FLP site-specific recombinase coding sequence and methods for its use. This genetically engineered FLP gene displays a marked increase in recombination efficiency compared to the native FLP gene and is therefore useful in a wide array of molecular applications.

Claims

exact text as granted — not AI-modified
1 - 49 . (canceled) 
     
     
         50 . A transgenic non-human organism comprising a nucleic acid molecule comprising an optimized FLP recombinase coding sequence having the sequence of SEQ NO:1 that provides an enhanced recombinase activity in a cell comprising and expressing the nucleic acid molecule. 
     
     
         51 . The transgenic non-human organism of  claim 50 , wherein the nucleic acid molecule comprising the optimized FLP recombinase coding sequence has at least about 90% sequence identity to the sequence of SEQ ID NO:1. 
     
     
         52 . The transgenic non-human organism of  claim 50 , wherein said transgenic non-human organism is an invertebrate. 
     
     
         53 . The transgenic non-human organism of  claim 50 , wherein said transgenic non-human organism is a vertebrate. 
     
     
         54 . The transgenic non-human organism of  claim 50 , wherein said transgenic non-human organism is a mammal. 
     
     
         55 . The transgenic non-human organism of  claim 54 , wherein said transgenic non-human organism is a mouse. 
     
     
         56 . A transgenic mouse comprising an expression construct comprising a nucleic acid molecule comprising an optimized FLP recombinase coding sequence having the sequence of SEQ ID NO:1 that provides an enhanced recombinase activity in a cell comprising and expressing the nucleic acid molecule. 
     
     
         57 . The transgenic mouse of  claim 56 , wherein the nucleic acid molecule comprising the optimized FLP recombinase coding sequence has at least about 90% sequence identity to the sequence of SEQ ID NO:1.

Join the waitlist — get patent alerts

Track US2016083699A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.